Bernal ML - Search Results

1

Severe ipsilateral musculoskeletal involvement in a Cornelia de Lange patient with a novel NIPBL mutation.

Baquero-Montoya C, Gil-Rodríguez MC, Hernández-Marcos M, Teresa-Rodrigo ME, Vicente-Gabas A, Bernal ML, Casale CH, Bueno-Lozano G, Bueno-Martínez I, Queralt E, Villa O, Hernando-Davalillo C, Armengol L, Gómez-Puertas P, Puisac B, Selicorni A, Ramos FJ, Pié J. Baquero-Montoya C, et al. Among authors: bernal ml. Eur J Med Genet. 2014 Sep;57(9):503-9. doi: 10.1016/j.ejmg.2014.05.006. Epub 2014 May 27. Eur J Med Genet. 2014. PMID: 24874887

2

Frequency distribution of C3435T mutation in exon 26 of the MDR1 gene in a Spanish population.

Bernal ML, Sinues B, Fanlo A, Mayayo E. Bernal ML, et al. Ther Drug Monit. 2003 Feb;25(1):107-11. doi: 10.1097/00007691-200302000-00016. Ther Drug Monit. 2003. PMID: 12548153

3

Effects of growth hormone deficiency and rhGH replacement therapy on the 6beta-hydroxycortisol/free cortisol ratio, a marker of CYP3A activity, in growth hormone-deficient children.

Sinués B, Mayayo E, Fanlo A, Mayayo E Jr, Bernal ML, Bocos P, Bello E, Labarta JI, Ferrández-Longás A. Sinués B, et al. Among authors: bernal ml. Eur J Clin Pharmacol. 2004 Oct;60(8):559-64. doi: 10.1007/s00228-004-0806-4. Epub 2004 Sep 7. Eur J Clin Pharmacol. 2004. PMID: 15365655

4

Influence of the urine flow rate on some caffeine metabolite ratios used to assess CYP1A2 activity.

Sinués B, Fanlo A, Bernal ML, Mayayo E, Soriano MA, Martínez-Ballarin E. Sinués B, et al. Among authors: bernal ml. Ther Drug Monit. 2002 Dec;24(6):715-21. doi: 10.1097/00007691-200212000-00006. Ther Drug Monit. 2002. PMID: 12451287 Clinical Trial.

5

Omeprazole treatment: genotoxicity biomarkers, and potential to induce CYP1A2 activity in humans.

Sinués B, Fanlo A, Bernal ML, Val M, Mayayo E. Sinués B, et al. Among authors: bernal ml. Hum Exp Toxicol. 2004 Mar;23(3):107-13. doi: 10.1191/0960327104ht431oa. Hum Exp Toxicol. 2004. PMID: 15119530 Clinical Trial.

6

MDR-1 C3435T genetic polymorphism and tobacco-related lung cancer.

Sinués B, Fanlo A, Bernal ML, Mayayo E, Bello S, Rubio E, Isla D. Sinués B, et al. Among authors: bernal ml. Oncology. 2003;64(2):183-5. doi: 10.1159/000067770. Oncology. 2003. PMID: 12566917 No abstract available.

7

Five caffeine metabolite ratios to measure tobacco-induced CYP1A2 activity and their relationships with urinary mutagenicity and urine flow.

Sinués B, Sáenz MA, Lanuza J, Bernal ML, Fanlo A, Juste JL, Mayayo E. Sinués B, et al. Among authors: bernal ml. Cancer Epidemiol Biomarkers Prev. 1999 Feb;8(2):159-66. Cancer Epidemiol Biomarkers Prev. 1999. PMID: 10067814

8

Ten percent of North Spanish individuals carry duplicated or triplicated CYP2D6 genes associated with ultrarapid metabolism of debrisoquine.

Bernal ML, Sinues B, Johansson I, McLellan RA, Wennerholm A, Dahl ML, Ingelman-Sundberg M, Bertilsson L. Bernal ML, et al. Pharmacogenetics. 1999 Oct;9(5):657-60. Pharmacogenetics. 1999. PMID: 10591547 No abstract available.

9

Six mutagenicity assays in exposure biomonitoring of patients receiving carbamazepine for epilepsy or trigeminal neuralgia.

Sinués B, Gazulla J, Bernal ML, Lanuza J, Fanlo A, Saenz MA, Barolome M. Sinués B, et al. Among authors: bernal ml. Mutat Res. 1995 Apr;334(2):259-65. doi: 10.1016/0165-1161(95)90019-5. Mutat Res. 1995. PMID: 7885380

10

Cytogenetic study in peripheral blood lymphocytes from asthmatic patients receiving continued therapy with theophylline.

Sinues B, Broto A, Suarez MA, Duce F, Martinez-Berganza A, Bernal ML. Sinues B, et al. Among authors: bernal ml. Mutat Res. 1992 Oct;280(4):271-7. doi: 10.1016/0165-1218(92)90057-7. Mutat Res. 1992. PMID: 1382228

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

58 results

Search Page